Study of PX-866 and Docetaxel in Solid Tumors
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01204099. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1/2 Study of PX-866 and Docetaxel in Patients With Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Phase 1: To determine the maximally tolerated dose (MTD) or recommended dose (RD) and any potential efficacy of PX-866 in combination with docetaxel in patients with solid tumors. Phase 2: To determine the antitumor activity and safety of PX-866 in combination with docetaxel versus docetaxel alone in patients with NSCLC or SCCHN.
Study identification
- NCT ID
- NCT01204099
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 223 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Dec 2013 (Actual)
- Completion
- Feb 2014 (Actual)
- Last update posted
- May 16, 2018
2010 – 2014
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Southwest Cancer Care | Escondido | California | 92025 | — |
| Bay Area Cancer Research Group, LLC | Pleasant Hill | California | 94523 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Eastern Colorado Health Care System - Denver VA | Denver | Colorado | 80220 | — |
| Cancer Center of Pasco-Pinellas | Holiday | Florida | 34619 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| John Hopkins University | Baltimore | Maryland | 21231 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| New Mexico Cancer Care Alliance | Albuquerque | New Mexico | 87131 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| New York Oncology, Hematology | Latham | New York | 12110 | — |
| Beth Israel Hospital | New York | New York | 10003 | — |
| New York University Medical Center | New York | New York | 10016 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Northwest Cancer Specialists | Tualatin | Oregon | 97062 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15232 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Texas Oncology - South Austin | Austin | Texas | 78745 | — |
| Mary Crowley Cancer Center | Dallas | Texas | 75201 | — |
| Texas Oncology - Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Oncology and Hematology Associates of SW Virginia, DBA Blue Ridge Cancer Care | Christiansburg | Virginia | 24073 | — |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | — |
| Virginia Oncology Associates | Newport News | Virginia | 23606 | — |
| Columbia Basin Hematology & Oncology | Kennewick | Washington | 99336 | — |
| Medical Oncology Associates | Spokane | Washington | 99208 | — |
| Yakima Valley Memorial Hospital/North Star Lodge | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01204099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2018 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.